Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.53 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.39 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.39 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.39 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.38 |
| ▸ | DPP7 | Q9UHL4 | 9/20 | 0.38 |
| ▸ | DPP8 | Q6V1X1 | 4/20 | 0.38 |
| ▸ | DPP9 | Q86TI2 | 4/20 | 0.38 |
| ▸ | DPP4 | P27487 | 1/20 | 0.38 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.38 |
| ▸ | NOS2 | P35228 | 4/20 | 0.36 |
| ▸ | NOS3 | P29474 | 2/20 | 0.36 |
| ▸ | NOS1 | P29475 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | APEX1 | P27695 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2516159 | 0.94 | GSR (0.45) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL28035725 | 0.80 | NOS2 (0.56) | CPB2NOS2NOS3NOS1CYP1A2 | |
| SCHEMBL1404247 | 0.79 | GSR (0.61) | GSRGNAI3GNAO1GNAI1RNPEP | |
| SCHEMBL28305389 | 0.79 | GSR (0.61) | GSRGNAI3GNAO1GNAI1RNPEP | |
| SCHEMBL20240364 | 0.79 | GSR (0.61) | GSRGNAI3GNAO1GNAI1RNPEP | |
| SCHEMBL344574 | 0.79 | GSR (0.61) | GSRGNAI3GNAO1GNAI1RNPEP | |
| SCHEMBL20945360 | 0.79 | GSR (0.47) | GSRGNAI3GNAO1GNAI1RNPEP | |
| SCHEMBL16412363 | 0.79 | GSR (0.47) | GSRGNAI3GNAO1GNAI1RNPEP | |
| SCHEMBL2887132 | 0.78 | GSR (0.55) | GSRGNAI3GNAO1GNAI1RNPEP | |
| SCHEMBL169864 | 0.78 | GSR (0.59) | GSRGNAI3GNAO1GNAI1RNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12612370-B2 | Amino acid compositions | THERMOLIFE INTERNATIONAL, LLC (US) | 2026-04-28 | — | — | US | disclosed |
| US-12577210-B2 | Amino acid compositions | THERMOLIFE INTERNATIONAL, LLC (US) | 2026-03-17 | — | — | US | disclosed |
| US-12577209-B2 | Amino acid compositions | THERMOLIFE INTERNATIONAL, LLC (US) | 2026-03-17 | — | — | US | disclosed |
| US-12540119-B2 | Amino acid compositions | THERMOLIFE INTERNATIONAL, LLC (US) | 2026-02-03 | — | — | US | disclosed |
| US-12522568-B2 | Amino acid compositions | THERMOLIFE INTERNATIONAL, LLC (US) | 2026-01-13 | — | — | US | disclosed |
| US-12473261-B2 | Amino acid compositions | THERMOLIFE INTERNATIONAL, LLC (US) | 2025-11-18 | — | — | US | disclosed |
| US-12448357-B1 | Amino acid compositions | THERMOLIFE INTERNATIONAL, LLC (US) | 2025-10-21 | — | — | US | disclosed |
| US-20250171406-A1 | AMINO ACID COMPOSITIONS | THERMOLIFE INTERNATIONAL, LLC | 2025-05-29 | — | — | US | disclosed |
| US-20250162999-A1 | AMINO ACID COMPOSITIONS | THERMOLIFE INTERNATIONAL, LLC | 2025-05-22 | — | — | US | disclosed |
| US-20250162998-A1 | AMINO ACID COMPOSITIONS | THERMOLIFE INTERNATIONAL, LLC | 2025-05-22 | — | — | US | disclosed |
| US-10426792-B1 | Amino acid compositions | THERMOLIFE INTERNATIONAL, LLC (US) | 2019-10-01 | — | — | US | disclosed |
| US-10426750-B1 | Amino acid supplement formulations | THERMOLIFE INTERNATIONAL, LLC (US) | 2019-10-01 | — | — | US | disclosed |
| US-8957101-B1 | Amino acid compositions | THERMOLIFE INTERNATIONAL, LLC (US) | 2015-02-17 | — | — | US | disclosed |
| US-8957100-B1 | Amino acid compositions | THERMOLIFE INTERNATIONAL, LLC (US) | 2015-02-17 | — | — | US | disclosed |
| US-8952046-B1 | Amino acid compositions | THERMOLIFE INTERNATIONAL, LLC (US) | 2015-02-10 | — | — | US | disclosed |
| US-8952045-B1 | Amino acid compositions | THERMOLIFE INTERNATIONAL, LLC (US) | 2015-02-10 | — | — | US | disclosed |
| US-8466187-B2 | Amino acid compositions | THERMOLIFE INTERNATIONAL, LLC (US) | 2013-06-18 | — | — | US | disclosed |
| US-8455531-B2 | Amino acid compositions | THERMOLIFE INTERNATIONAL, LLC (US) | 2013-06-04 | — | — | US | disclosed |
| US-8344014-B2 | — | — | 2013-01-01 | — | — | US | disclosed |
| US-20110313043-A1 | Amino Acid Compositions | THERMOLIFE INTERNATIONAL, LLC (US) | 2011-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12473261-B2 | Amino acid compositions | ASNS, GLUL, ARGLU1 | GSR 2443/4885GNAI3 4197/4885GNAO1 3843/4885 |
| US-12612370-B2 | Amino acid compositions | TNNT2, NPR1, NOS2 | GSR 2949/4885GNAI3 4469/4885GNAO1 3661/4885 |
| US-12448357-B1 | Amino acid compositions | SLC6A15, SLC1A5, SLC6A19 | GSR 3175/4885GNAI3 2404/4885GNAO1 2247/4885 |
| US-12540119-B2 | Amino acid compositions | NOS2, NOS1, NOS3 | GSR 1583/4885GNAI3 4035/4885GNAO1 3600/4885 |
| US-12577209-B2 | Amino acid compositions | ARG1, NOS1, NOS2 | GSR 2870/4885GNAI3 4688/4885GNAO1 4321/4885 |
| US-20250171406-A1 | AMINO ACID COMPOSITIONS | ASNS, GLUL, ARGLU1 | GSR 2608/4885GNAI3 4227/4885GNAO1 3824/4885 |
| US-12577210-B2 | Amino acid compositions | NPR1, SLC1A5, SLC6A15 | GSR 3566/4885GNAI3 4468/4885GNAO1 4166/4885 |
| US-20250162999-A1 | AMINO ACID COMPOSITIONS | ASNS, SLC1A5, BCAT2 | GSR 3531/4885GNAI3 3026/4885GNAO1 2639/4885 |
| US-20250162998-A1 | AMINO ACID COMPOSITIONS | ASNS, SLC1A5, BCAT2 | GSR 3531/4885GNAI3 3026/4885GNAO1 2639/4885 |
| US-20110313043-A1 | Amino Acid Compositions | ARGLU1, AADAT, MUSK | GSR 412/4885GNAI3 2943/4885GNAO1 1474/4885 |
| US-10426750-B1 | Amino acid supplement formulations | ARGLU1, ARG1, PYGM | GSR 56/4885GNAI3 3382/4885GNAO1 2155/4885 |
| US-10426792-B1 | Amino acid compositions | SLC10A2, SLC6A6, SLC6A15 | GSR 1279/4885GNAI3 4178/4885GNAO1 2842/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.